Evidence map›Paper›PMID 33202864›Full record

ArticleCancers2020

The 40bp Indel Polymorphism rs150550023 in the

Heidi Miedl, Bianca Dietrich, Klaus Kaserer, Martin Schreiber

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Heidi MiedlDepartment of Obstetrics & Gynecology, Medical University of Vienna, 1090 Vienna, Austria.
Bianca DietrichDepartment of Obstetrics & Gynecology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-4640-0301
Klaus KasererLabor Kaserer, Salzer and Beer, 1030 Vienna, Austria.
Martin SchreiberDepartment of Obstetrics & Gynecology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-1102-7789
Medical University of Vienna · ATComprehensive Cancer Center Vienna · AT

Funding

Oesterreichische Nationalbank 12994
6 · The paper itself

Abstract

Most low-penetrance genetic risk factors for cancer are located in noncoding regions, presumably altering the regulation of neighboring genes. The poorly characterized Indel polymorphism rs150550023 (rs3730485; del1518) in the promoter of

Indexed as

age at onsetbreast cancerIndel polymorphismMDM2 (human homolog of mouse double minute 2)mRNA expressionprognosisrs150550023rs3730485TP53tumor tissue

Identifiers

PMID33202864
PMCPMC7697608
OpenAlexW3102898874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.